- May 01, 2020
STANFORD, Calif. (KRON) — The FDA has approved a drug on an emergency basis for the treatment of COVID-19.
The drug is called remdesivir and it comes from Foster City based Gilead Sciences.
The drug is authorized to be used with patients severely ill with the virus.
Stanford has two clinical trials of remdesivir. The focus is on safety, tolerability and efficacy. The studies were approved in record time.